FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4365143477> ?p ?o ?g. }

• W4365143477 abstract "Whether serum apolipoprotein B (ApoB) is a risk factor for the development of Chronic kidney disease (CKD) has not been fully established in the general population. Therefore, our study evaluated the correlation between serum ApoB level and CKD to look for an alternative approach for CKD prevention and treatment in the general population.There were 146,533 participants in this cross-sectional study. 3,325 participants with more than 2 measurements were enrolled in the retrospective longitudinal study with at least a 3-year follow-up. ApoB was measured by the immunoturbidimetric method in 6 centers. Our study defined CKD as an estimated glomerular filtration rate (eGFR) < 90 mL/min/1.73 m2. The Spearman rank correlation analysis and the Random Forest algorithm were applied to rank the importance of variables determining the levels of eGFR. We used the logistic regression model to explain the correlation between serum ApoB and CKD. We used the Cox model to detect the correlation between baseline serum ApoB and the subsequent occurrence of CKD.Based on a cross-sectional study, 66.5% of the participants were males, with a median age of 49 (interquartile range [IQR] 43-55). Compared to the non-CKD group, the CKD group has higher levels of lipid profile and fasting glucose as well as the proportion of hypertension and hyperuricemia. The Spearman rank correlation analysis and the Random Forest algorithm revealed that ApoB has the highest correlation with eGFR decline among lipid profiles. The logistic regression analysis revealed that ApoB had a positive correlation with the prevalence of CKD after fully controlling confounders (odds ratio [OR], 1.07; 95% confidence interval [CI]: 1.02-1.11). Moreover, baseline ApoB level was correlated with a new-onset CKD in the longitudinal cohort after full adjustment for confounding factors (hazard ratio [HR], 1.61; 95% CI: 1.02-2.54). The correlation between ApoB level and the new-onset CKD was consistently observed in all sensitivity analyses.Serum ApoB had the strongest correlation with CKD among all lipid variables. Moreover, high serum ApoB levels might precede the occurrence of CKD, suggesting that monitoring and reducing serum ApoB levels may provide an alternative method to prevent and treat CKD." @default.
• W4365143477 created "2023-04-13" @default.
• W4365143477 creator A5003981788 @default.
• W4365143477 creator A5015523140 @default.
• W4365143477 creator A5015805770 @default.
• W4365143477 creator A5017379979 @default.
• W4365143477 creator A5018040407 @default.
• W4365143477 creator A5036993436 @default.
• W4365143477 creator A5049357212 @default.
• W4365143477 creator A5050618539 @default.
• W4365143477 creator A5068484115 @default.
• W4365143477 creator A5077165659 @default.
• W4365143477 creator A5081814390 @default.
• W4365143477 creator A5090815103 @default.
• W4365143477 date "2023-04-12" @default.
• W4365143477 modified "2023-09-30" @default.
• W4365143477 title "The association of apolipoprotein B with chronic kidney disease in the Chinese population" @default.
• W4365143477 cites W1956489988 @default.
• W4365143477 cites W1968949098 @default.
• W4365143477 cites W1987603059 @default.
• W4365143477 cites W1992283514 @default.
• W4365143477 cites W1996258616 @default.
• W4365143477 cites W2033896075 @default.
• W4365143477 cites W2054395645 @default.
• W4365143477 cites W2078591470 @default.
• W4365143477 cites W2108804344 @default.
• W4365143477 cites W2113760558 @default.
• W4365143477 cites W2131750038 @default.
• W4365143477 cites W2141019052 @default.
• W4365143477 cites W2143181482 @default.
• W4365143477 cites W2145732657 @default.
• W4365143477 cites W2152188478 @default.
• W4365143477 cites W2437173244 @default.
• W4365143477 cites W2546992884 @default.
• W4365143477 cites W2552342544 @default.
• W4365143477 cites W2735301415 @default.
• W4365143477 cites W2749237115 @default.
• W4365143477 cites W2789006309 @default.
• W4365143477 cites W2793955071 @default.
• W4365143477 cites W2897257410 @default.
• W4365143477 cites W2904815814 @default.
• W4365143477 cites W2937722057 @default.
• W4365143477 cites W3005957464 @default.
• W4365143477 cites W3006604834 @default.
• W4365143477 cites W3012813218 @default.
• W4365143477 cites W3030426760 @default.
• W4365143477 cites W3043910493 @default.
• W4365143477 cites W3136636027 @default.
• W4365143477 cites W3162098185 @default.
• W4365143477 cites W3173408181 @default.
• W4365143477 cites W3200090851 @default.
• W4365143477 cites W3211755826 @default.
• W4365143477 cites W4205120583 @default.
• W4365143477 cites W4206996545 @default.
• W4365143477 cites W4225697240 @default.
• W4365143477 cites W4229445094 @default.
• W4365143477 cites W4292764144 @default.
• W4365143477 cites W4296389197 @default.
• W4365143477 doi "https://doi.org/10.3389/fendo.2023.1083614" @default.
• W4365143477 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37124758" @default.
• W4365143477 hasPublicationYear "2023" @default.
• W4365143477 type Work @default.
• W4365143477 citedByCount "0" @default.
• W4365143477 crossrefType "journal-article" @default.
• W4365143477 hasAuthorship W4365143477A5003981788 @default.
• W4365143477 hasAuthorship W4365143477A5015523140 @default.
• W4365143477 hasAuthorship W4365143477A5015805770 @default.
• W4365143477 hasAuthorship W4365143477A5017379979 @default.
• W4365143477 hasAuthorship W4365143477A5018040407 @default.
• W4365143477 hasAuthorship W4365143477A5036993436 @default.
• W4365143477 hasAuthorship W4365143477A5049357212 @default.
• W4365143477 hasAuthorship W4365143477A5050618539 @default.
• W4365143477 hasAuthorship W4365143477A5068484115 @default.
• W4365143477 hasAuthorship W4365143477A5077165659 @default.
• W4365143477 hasAuthorship W4365143477A5081814390 @default.
• W4365143477 hasAuthorship W4365143477A5090815103 @default.
• W4365143477 hasBestOaLocation W43651434771 @default.
• W4365143477 hasConcept C101601086 @default.
• W4365143477 hasConcept C105795698 @default.
• W4365143477 hasConcept C117220453 @default.
• W4365143477 hasConcept C119060515 @default.
• W4365143477 hasConcept C126322002 @default.
• W4365143477 hasConcept C134018914 @default.
• W4365143477 hasConcept C151956035 @default.
• W4365143477 hasConcept C159641895 @default.
• W4365143477 hasConcept C159744936 @default.
• W4365143477 hasConcept C2524010 @default.
• W4365143477 hasConcept C2778163477 @default.
• W4365143477 hasConcept C2778653478 @default.
• W4365143477 hasConcept C2779721657 @default.
• W4365143477 hasConcept C2779881121 @default.
• W4365143477 hasConcept C2908647359 @default.
• W4365143477 hasConcept C33923547 @default.
• W4365143477 hasConcept C62746215 @default.
• W4365143477 hasConcept C71924100 @default.
• W4365143477 hasConcept C90924648 @default.
• W4365143477 hasConcept C99454951 @default.
• W4365143477 hasConceptScore W4365143477C101601086 @default.
• W4365143477 hasConceptScore W4365143477C105795698 @default.
• W4365143477 hasConceptScore W4365143477C117220453 @default.

• next